128
Views
0
CrossRef citations to date
0
Altmetric
Original Research

The Use of the Japanese Public Financial Support Has Positive Impact on Persistence with Outpatient Treatments for Schizophrenia: Single-center Retrospective Cohort Study in Japan

ORCID Icon, , ORCID Icon, , , , , & show all
Pages 169-175 | Published online: 02 Feb 2021

References

  • Rubin A, Springer DW, Trawver K, eds. Clinician’s Guide to Evidence-Based Practice Psychosocial Treatment of Schizophrenia. New Jersey: Wiley & Sons; 2010.
  • Liberman RP. Recovery from Disability: Manual of Psychiatric Rehabilitation. Washington DC: American Psychiatric Publishing Inc; 2008.
  • El-Mallakh P, Findlay J. Strategies to improve medication adherence in patients with schizophrenia: the role of support services. Neuropsychiatr Dis Treat. 2015;11:1077–1090. doi:10.2147/NDT.S56107
  • Crown WH, Neslusan C, Russo PA, Holzer S, Ozminkowski R, Croghan T. Hospitalization and total medical costs for privately insured persons with schizophrenia. Adm Policy Ment Health. 2001;28:335–351. doi:10.1023/A:1011139215761
  • Robinson D, Woerner MG, Alvir JMJ, et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry. 1999;56(3):241–247. doi:10.1001/archpsyc.56.3.241
  • Novick D, Haro JM, Suarez D, Perez V, Dittmann RW, Haddad PM. Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Res. 2010;176(2–3):109–113. doi:10.1016/j.psychres.2009.05.004
  • Slade M, Amering M, Oades LG. Recovery: an international perspective. Epidemiol Psichiatr Soc. 2008;17(2):128–137. doi:10.1017/S1121189X00002827
  • Leamy M, Bird V, Le Boutillier C, Williams J, Slade M. Conceptual framework for personal recovery in mental health: systematic review and narrative synthesis. Br J Psychiatry. 2011;199(6):445–452. doi:10.1192/bjp.bp.110.083733
  • Kuwabara H, Saito Y, Mahlich J. Adherence and rehospitalizations in patients with schizophrenia; evidence from Japanese claim data. Neuropsychiatr Dis Treat. 2015;11:935–940.
  • Nosé M, Barbui C, Gray R, Tansella M. Clinical interventions for treatment non-adherence in psychosis: meta-analysis. Br J Psychiatry. 2003;183:197–206. doi:10.1192/bjp.183.3.197
  • Giuffrida A, Torgerson DJ. Should we pay the patient? Review of financial incentives to enhance patient compliance. BMJ. 1997;315(7110):703–707. doi:10.1136/bmj.315.7110.703
  • Priebe S, Yeeles K, Bremner S. Effectiveness of financial incentives to improve adherence to maintenance treatment with antipsychotics: cluster randomised controlled trial. BMJ. 2013;347(7930):f5847. doi:10.1136/bmj.f5847
  • Sado M, Inagaki A, Koreki A, et al. The cost of schizophrenia in Japan. Neuropsychiatr Dis Treat. 2013;9:787–798. doi:10.2147/NDT.S41632
  • World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization; 1992.
  • Kishimoto T, Agarwal V, Kishi T, Leucht S, Kane JM, Correll CU. Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics. Mol Psychiatry. 2013;18:53–66. doi:10.1038/mp.2011.143
  • Ministry of Health, Labour and Welfare [PDF on the Internet]. Tokyo. Medical system for services and supports for personas with disabilities; 2020. Available from: https://www.mhlw.go.jp/english/wp/wp-hw5/dl/23010902e.pdf. Accessed August 24, 2020.
  • Ministry of Health, Labour and Welfare [PDF on the Internet]. Tokyo. System of medical payment for services and supports for persons with disabilities; 2010. Available from: https://www.mhlw.go.jp/english/wp/wp-hw4/dl/health_care_and_welfare_measures_for_people_with_physical_disabillities/2011071904.pdf. Accessed August 24, 2020.
  • Ministry of Health, Labour and Welfare. [PDF on the Internet]. Tokyo. Health care and welfare measures for persons with disabilities: benefits for welfare services and supports for persons with disabilities; 2011. Available from: https://www.mhlw.go.jp/english/wp/wp-hw6/dl/09e.pdf. Accessed August 24, 2020.
  • Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41–55. doi:10.1093/biomet/70.1.41
  • Stukel TA, Fisher ES, Wennberg DE, Alter DA, Gottlieb DJ, Vermeulen MJ. Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA. 2007;297(3):278–285. doi:10.1001/jama.297.3.278
  • Connors AF, Speroff T, Dawson NV, et al. The effectiveness of right heart catheterization in the initial care of critically III patients. JAMA. 1996;276(11):889–897. doi:10.1001/jama.1996.03540110043030
  • Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–458. doi:10.1038/bmt.2012.244
  • Arikawa M, Ota K, Azekawa T. The influence of psychiatric day care on the continuation of treatment for patients with schizophrenia: a retrospective cohort study in Japan. Soc Work Ment Health. 2019;17:1–12. doi:10.1080/15332985.2019.1610543
  • Arikawa M, Ota K, Azekawa T. The influence of the psychiatric day care on the continuation of treatments for the patients with bipolar disorder: single-center retrospective cohort study in Japan. Soc Work Ment Health. 2020;18:1–11. doi:10.1080/15332985.2020.1726552
  • Mitchell MS, Goodman JM, Alter DA, et al. Financial incentives for exercise adherence in adults: systematic review and meta-analysis. Am J Prev Med. 2013;45(5):658–667. doi:10.1016/j.amepre.2013.06.017
  • Suzuki Y, Yasumura S, Fukao A, Otani K. Associated factors of rehospitalization among schizophrenic patients. Psychiatry Clin Neurosci. 2003;57(6):555–561. doi:10.1046/j.1440-1819.2003.01167.x
  • Sutherland K, Christianson JB, Leatherman S. Impact of targeted financial incentives on personal health behavior. Med Care Res Rev. 2008;65(6_suppl):36S–78S. doi:10.1177/1077558708324235
  • Ministry of Health, Labour and Welfare [PDF on the Internet]. Tokyo. Results of the survey conducted to the recipients of the medical expenses for services and supports for persons with disabilities; 2017. Available from: https://www.mhlw.go.jp/file/05-Shingikai-12601000-Seisakutoukatsukan-Sanjikanshitsu_Shakaihoshoutantou/0000185303.pdf. Accessed August 24, 2020.
  • Ministry of Health, Labour and Welfare [PDF on the Internet]. Tokyo. Comprehensive survey of living conditions; 2018. Available from: https://www.mhlw.go.jp/toukei/saikin/hw/k-tyosa/k-tyosa17/dl/10.pdf. Accessed August 24, 2020.
  • Brook RH, Keeler EB, Lohr KN, et al. The Health Insurance Experiment: A Classic RAND Study Speaks to the Current Health Care Reform Debate. Santa Monica, CA: RAND Corporation; 2006.
  • Yoshida A, Takagi S. Effects of the reform of the social medical insurance system in Japan. Japan Econ Rev. 2002;53:444–465. doi:10.1111/1468-5876.00238
  • Hatzenbuehler ML. Structural stigma: research evidence and implications for psychological science. Am Psychol. 2016;71(8):742–751. doi:10.1037/amp0000068
  • Jiang Y, Ni W. Estimating the impact of adherence to and persistence with atypical antipsychotic therapy on health care costs and risk of hospitalization. Pharmacotherapy. 2015;35(9):813–822. doi:10.1002/phar.1634
  • Suzuki T, Uchida H, Watanabe K, Kashima H. Treatment target in schizophrenia: a critical review and a clinical suggestion. Psychopharmacol Bull. 2008;41(4):80–102.
  • Suzuki T. Which rating scales are regarded as ‘the standard’ in clinical trials for schizophrenia? A critical review. Psychopharmacol Bull. 2011;44(1):18–31.